IC

Unknown

237 clinical trials

Find Trials

Clinical Trials (237)

Showing 20 of 237 trialsScroll for more
NCT05030428Phase 32 sites

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

Active Not Recruiting
NCT05132075Phase 31 site

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

Active Not Recruiting
NCT04180397Phase 41 site

Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.

Recruiting
NCT06322420Not Applicable1 site

Behavioral Activation for Depression and Habitual Rumination

Active Not Recruiting
NCT04418856Not Applicable1 site

The Effects of Light Therapy to Treat Cancer-related Side Effects

Completed
NCT06429332Phase 41 site

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Recruiting

Metabolomics of Obstructive Sleep Apnea

Completed

NORDTREAT Prospective Study on Inflammatory Bowel Disease

Completed
NCT05849337Not Applicable1 site

The Lóa Study: A Brief Digital Intervention for Women With Intrusive Memories in the SAGA Cohort

Active Not Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Recruiting
NCT04023552Phase 32 sites

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Active Not Recruiting
NCT02032823Phase 31 site

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

Active Not Recruiting
NCT04307576Phase 31 site

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
NCT05133336Phase 21 site

Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

Completed

Pancreatic Cancer Early Detection Consortium

Recruiting
NCT04270760Phase 21 site

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Completed
NCT07465354Not Applicable1 site

OCD Summer Treatment Program for Adolescents in Iceland

Not Yet Recruiting

Modified Essential Frailty Toolset in Older Adults Undergoing Major Elective Surgery

Recruiting
NCT05767034Phase 31 site

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

Completed
NCT04701151Phase 41 site

NORTH-REG Dwell-Time Study

Active Not Recruiting